Betaconnect
Jump to navigation
Jump to search
Indications
- electronic automatic injector approved to treat relapsing- remitting multiple sclerosis[1]
Mechanism of action
- injects interferon beta-1b (Betaseron)
Notes
- available in early 2016
- Bayer HealthCare
More general terms
References
- ↑ 1.0 1.1 Bayer News Release. Sep 25, 2015 Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment. http://www.prnewswire.com/news-releases/bayer-receives-fda-approval-for-betaconnect---first-and-only-electronic-autoinjector-in-relapsing-remitting-multiple-sclerosis-rrms-treatment-300149438.html